Integrating Clinical Research into Epidemic Response: The Ebola Experience

Gerald Keusch, Keith McAdam, Patricia Cuff, Michelle Mancher, and Emily R. Busta National Academies of Sciences, Engineering, and Medicine (2017) C1
The 2014–2015 Ebola epidemic in western Africa was the longest <span class="attribute-to-highlight medbox">and</span> most deadly Ebola epidemic in history, resulting in 28,616 cases <span class="attribute-to-highlight medbox">and</span> 11,310 deaths in Guinea, Liberia, <span class="attribute-to-highlight medbox">and</span> Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Republic of Congo (then Zaire) <span class="attribute-to-highlight medbox">and</span> South Sudan (then Sudan). However, because all Ebola outbreaks prior to that in West Africa in 2014–2015 were relatively isolated <span class="attribute-to-highlight medbox">and</span> of short duration, little was known about how to best manage patients to improve survival, <span class="attribute-to-highlight medbox">and</span> there were no approved therapeutics or vaccines. When the World Heath Organization declared the 2014-2015 epidemic a public health emergency of international concern in August 2014, several teams began conducting formal clinical trials in the Ebola affected countries during the outbreak.